Telehealth Support for Artificial Respiration
(TEACH Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that telehealth technologies can improve adherence to treatment plans, as seen in studies with lung transplant recipients and COPD patients. These technologies help maintain high levels of adherence by providing immediate feedback, reminders, and simplifying communication between patients and healthcare providers.
12345The research on telehealth systems for managing conditions like asthma and transplant adherence shows that these systems are generally well-accepted and safe, with participants finding them helpful and easy to use. No significant safety concerns were reported in the studies, and participants often experienced improved adherence and satisfaction with the telehealth interventions.
16789The Telehealth-enabled support for SAT/SBT adherence treatment is unique because it uses telehealth technology to enhance adherence to artificial respiration protocols by providing immediate feedback, reminders, and educational support, which can help maintain high adherence levels over time, unlike traditional methods that may not offer such interactive and continuous support.
110111213Eligibility Criteria
This trial is for patients aged 16 or older who are in the ICU and on artificial breathing support. It's not for those who passed away within a day of being put on a ventilator or were already brain dead when admitted for organ donation.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive coordinated spontaneous awakening and breathing trials with telehealth-enabled support or usual audit and feedback
Follow-up
Participants are monitored for ventilator-free days and other clinical outcomes